Briefings Archive

Period:

RESEARCH BRIEFING
  • The remdesivir saga continues
POLICY BRIEFING
  • Covid-19 research faces challenges
  • Restarting the economy likely to worsen inequality
  • Remdesivir poised to obtain emergency use authorization despite mixed data

RESEARCH BRIEFING
  • Can alpha-1 adrenergic receptor antagonists prevent covid-19 cytokine storm?
  • News leak from the CORIMUNO-TOCI clinical trial
POLICY BRIEFING
  • Advanced service payments coming to a halt
  • States stockpile hydroxychloroquine despite FDA recommendations
  • Trump says meat processing plants must stay open

RESEARCH BRIEFING
  • SARS-CoV-2 spread in an air-conditioned restaurant in China
POLICY BRIEFING
  • Secretive group channeling ideas to the White House
  • Administration embraces telehealth

RESEARCH BRIEFING
  • Do people lose their sense of smell or taste when they have SARS-CoV-2?
  • Does confinement or shelter-in-place affect the mental health of children?
POLICY BRIEFING
  • Navajo Nation continues to disproportionately suffer from covid-19
  • New York City, other cities release updated race data for covid-19 fatality and hospitalization rates

(Week in Review)
POLICY BRIEFING
  • Reopening drama continues
  • Reimbursement for uninsured care
  • New stimulus package by the numbers
  • Changes in testing policy
  • Was the Bright light snuffed out?
  • Emergency use authorization leaves quality by the wayside

(Week in Review)
RESEARCH BRIEFING
  • BREAKING NEWS: Chloroquine trial halted; high doses deemed too harmful
  • What happens to children diagnosed with covid-19?
  • Early New York Hospital data emerges
  • Confirmed ways to decontaminate and reuse N95 masks

RESEARCH BRIEFING
  • BREAKING NEWS: Chloroquine trial halted; high doses deemed too harmful
POLICY BRIEFING
  • Changes in testing policy
  • Reimbursement for uninsured care
  • House passage of newest stimulus bill foreshadows fight to come

RESEARCH BRIEFING
  • Renin-Angiotensin System Inhibitors and COVID-19 Update
POLICY BRIEFING
  • UPDATE: Was the Bright light snuffed out?
  • Reopening drama continues

RESEARCH BRIEFING
  • The hydroxychloroquine drama continues
  • What happens to children diagnosed with covid-19?
POLICY BRIEFING
  • A Bright spot at BARDA flames out
  • New stimulus package by the numbers
  • Partisanship dominates pandemic management in Wisconsin

RESEARCH BRIEFING
  • Confirmed ways to decontaminate and reuse N95 masks
  • What is the optimum distance or formation to "social distance" when exercising outside?
POLICY BRIEFING
  • Bowling alone
  • Is a public-private partnership the cure for covid-19?

RESEARCH BRIEFING
  • Covid-19 cases are up in the United States. But where are the heart attacks?
  • Early New York Hospital data emerges
POLICY BRIEFING
  • A call to resume visa processing for foreign physicians
  • Emergency use authorization leaves quality by the wayside
  • More aid coming soon

RESEARCH BRIEFING
  • Why does universal testing for SARS-CoV-2 matter?
  • What's going on with Gildead's remdesivir clinical trial?
POLICY BRIEFING
  • Non-profit vaccine may be available in early 2021
  • Compounded sedation now available
  • Is Counting Covid-19 Death Toll State Dependent?

RESEARCH BRIEFING
  • Technical Review: COVID-19 Lung Injury is not High Altitude Pulmonary Edema
  • Headline misleads on remdesivir data. Two patients in study died. Was that more or less than expected?
POLICY BRIEFING
  • Governors prevail, Federalism is alive and well
  • Too little, too late, stimulus funds running out

RESEARCH BRIEFING
  • COVID-19 and African Americans
  • Post-mortem Covid-19 exposures?
POLICY BRIEFING
  • Catch me if you can
  • Putting medical students to work
  • Inadequate PPE leaves health care workers sick

RESEARCH BRIEFING
  • Universal testing in obstetrics reveals a high asymptomatic carrier rate for SARS-CoV-2
POLICY BRIEFING
  • Federal government sends healthcare disbursement
  • Plans to lift stay-at-home orders
  • The Newest Shortage

RESEARCH BRIEFING
  • New study questions the safety and efficacy of hydroxychloroquine for covid-19
  • Are chest x-rays reliable for diagnosing covid-19?
  • Autopsy findings of four patients with covid-19 in New Orleans
POLICY BRIEFING
  • Who is in charge, here?
  • Oyez, oyez, oyez
  • Hold the swab

RESEARCH BRIEFING
  • Compassionate Use of Remdesivir for Patients with Severe Covid-19
POLICY BRIEFING
  • Broader financial support for businesses
  • When will this all be over?
  • Reduce, reuse, recycle

RESEARCH BRIEFING
  • What do we know about doctors who have died from covid-19?
  • What happens to children who get covid-19 in the United States?
POLICY BRIEFING
  • Cessation of federal support
  • Rural America is not spared
  • Cases in correctional facilities on the rise

RESEARCH BRIEFING
  • SARS-CoV-2 and blood clots
  • One virus, several diseases?
POLICY BRIEFING
  • Expanded production quotas of controlled substances
  • More money needed
  • Defense Production Act in action

RESEARCH BRIEFING
  • Is the covid-19 pandemic concerning the general public?
POLICY BRIEFING
  • CDC begins search for the true denominator
  • Custody battles behind the front lines
  • An essential vote

RESEARCH BRIEFING
  • What happened to covid-19 patients admitted to the ICU in Italy?
  • From the archives of uninformative clickbait
POLICY BRIEFING
  • Quarantine requirements across state lines
  • Expanded face mask recommendations
  • Masks, at last

RESEARCH BRIEFING
  • Can a drug used to kill parasites fight SARS-Cov-2?
  • Can antihypertensives help to fight covid-19?
POLICY BRIEFING
  • Worsening supply shortages
  • US paying hospitals Medicare rates for covid-19 care for the uninsured
  • Share the immunity

RESEARCH BRIEFING
  • More studies on hydroxychloroquine, same “iffy” results
  • Does your blood type make you more susceptible to SARS-Cov-2?
POLICY BRIEFING
  • FDA Authorizes First Serology Test for SARS-CoV-2
  • Relaxed restrictions for controlled substances

RESEARCH BRIEFING
  • Chronic disease and covid-19 outcomes
  • Initial observations of covid-19 patients in critical care in three cities
POLICY BRIEFING
  • Stimulus checks may not be as automatic as advertised
  • FDA develops accelerated treatment pathway
  • US intelligence report suspects China lied about covid-19 infections

RESEARCH BRIEFING
  • Multiple patients on a single mechanical ventilator?
  • More estimates of the case-fatality rate (CFR) of covid-19
POLICY BRIEFING
  • FDA grants emergency authorization for medication
  • Changes to Medicare payment programs
  • Joint Commission supports provider-supplied PPE